Post-Marketing Surveillance of Adverse Events for the Recombinant Zoster Vaccine Among the Population over 50 Years Old in Hangzhou, China

Supporters

Support the authors with ResearchCoin

Tip RSC

Journal

Vaccines

Topics

Medicine

Epidemiology

Immunology

Internal Medicine

Pediatrics

Show all topics

DOI

10.3390/vaccines12121376

License

CC-BY